treosulfan has been researched along with Thalassemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, N; Ahmed, R; Bhurani, D; Halder, R; Kapoor, J; Mehta, P; Singh, A; Singh, R; Verma, M; Yadav, N | 1 |
| Bernardo, ME; Bertaina, A; La Nasa, G; Locatelli, F; Mastronuzzi, A | 1 |
2 other study(ies) available for treosulfan and Thalassemias
| Article | Year |
|---|---|
Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high risk.
Topics: Adolescent; Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclophosphamide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Intercellular Signaling Peptides and Proteins; Retrospective Studies; Thalassemia; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2022 |
The role of reduced intensity preparative regimens in patients with thalassemia given hematopoietic transplantation.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Busulfan; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Male; Thalassemia; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |